Ottobock SE & Co. KGaA (ETR:OBCK)

Germany flag Germany · Delayed Price · Currency is EUR
56.60
-1.40 (-2.41%)
At close: Apr 28, 2026
Market Cap 3.71B
Revenue (ttm) 1.68B
Net Income (ttm) 90.20M
Shares Out 63.99M
EPS (ttm) 1.44
PE Ratio 40.38
Forward PE 19.53
Dividend 0.97 (1.67%)
Ex-Dividend Date n/a
Volume 10,404
Average Volume 19,878
Open 59.70
Previous Close 58.00
Day's Range 56.60 - 59.70
52-Week Range 45.56 - 76.35
Beta n/a
RSI 55.29
Earnings Date May 6, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities; mechanical prostheses and technologically sophistic... [Read more]

Sector Healthcare
Founded 1919
Employees 10,365
Stock Exchange Deutsche Börse Xetra
Ticker Symbol OBCK
Full Company Profile

Financial Performance

In 2025, Ottobock SE & Co. KGaA's revenue was 1.68 billion, an increase of 4.69% compared to the previous year's 1.60 billion. Earnings were 90.20 million, an increase of 198.68%.

Financial Statements

News

Ottobock SE & Co. KGaA Earnings Call Transcript: Q4 2025

Delivered double-digit revenue and EBITDA growth in 2025, with strong cash flow and margin expansion. Guidance for 2026 is conservative, reflecting a robust innovation pipeline and prudent assumptions on external events.

2 months ago - Transcripts

Ottobock SE & Co. KGaA Earnings Call Transcript: Q3 2025

Core revenue grew 13.6% year-to-date, with strong EBITDA margin expansion and robust free cash flow. Growth was broad-based across regions and segments, driven by innovation, new product launches, and successful M&A. Guidance for 2025 is narrowed to the upper end, with continued momentum expected.

5 months ago - Transcripts